Fred Aslan - President and CEO, Director at Artiva Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
ARTV on Nasdaq
All Insider Reports
All Insider Reports

Fred Aslan - trading volume in the past year for Artiva Biotherapeutics, Inc.

Holdings reported by Fred Aslan for Artiva Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,562,198 $6,248,792 $4.00 15 Feb 2026 Direct
Employee Stock Option (Right to Buy) 0 12 Dec 2025 Direct Common Stock

Transactions reported by Fred Aslan for Artiva Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.